Market for HIV Prevention Drugs May More Than Double, Citi Says

(Bloomberg) -- Even with approval approaching for a generic of the first medicine to prevent HIV, the U.S. market for similar medicines may more than double by 2030, a Citi analyst predicts.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.